Phase IV Study on the Effects of Onabotulinumtoxina Intradetrusorial Injections on Bladder Expression of NGF, TRKA. P75 and TRPV1 in Patients with Detrusor Overactivity.
Phase of Trial: Phase IV
Latest Information Update: 03 Jul 2012
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Biomarker; Pharmacodynamics
- 03 Jul 2012 New trial record